1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naive B cells

被引:62
|
作者
Geldmeyer-Hilt, Kerstin [1 ]
Heine, Guido [1 ,2 ]
Hartmann, Bjoern [1 ]
Baumgrass, Ria [2 ]
Radbruch, Andreas [2 ]
Worm, Margitta [1 ]
机构
[1] Charite, Allergie Ctr Charite, CCM, Klin Dermatol & Allergol, D-10117 Berlin, Germany
[2] Deutsch Rheuma Forschungszentrum Berlin, D-10117 Berlin, Germany
关键词
Vitamin D; Calcitriol; Vitamin D receptor; NF-kappa B; Naive B cells; VITAMIN-D-RECEPTOR; DOWN-REGULATION; P50; SUBUNIT; GENE; LYMPHOCYTES; PROMOTER; SUBPOPULATIONS; RESPONSES; DEFECTS;
D O I
10.1016/j.bbrc.2011.03.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1 alpha,25-dihydroxyvitamin D-3 (calcitriol), the bioactive metabolite of vitamin D, modulates the activation and inhibits IgE production of anti-CD40 and IL-4 stimulated human peripheral B cells. Engagement of CD40 results in NF-kappa B p50 activation, which is essential for the class switch to IgE. Herein, we investigated by which mechanism calcitriol modulates NF-kappa B mediated activation of human naive B cells. Naive B cells were predominantly targeted by calcitriol in comparison with memory B cells as shown by pronounced induction of the VDR target gene cyp24a1. Vitamin D receptor activation resulted in a strongly reduced p105/p50 protein and mRNA expression in human naive B cells. This effect is mediated by impaired nuclear translocation of p65 and consequently reduced binding of p65 to its binding site in the p105 promoter. Our data indicate that the vitamin D receptor reduces NF-kappa B activation by interference with NF-kappa B p65 and p105. Thus, the vitamin D receptor inhibits costimulatory signal transduction in naive B cells, namely by reducing CD40 signaling. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:699 / 702
页数:4
相关论文
共 50 条
  • [32] Characterization of the activation function-2 domain of the human 1,25-dihydroxyvitamin D3 receptor
    Nakajima, S
    Yamagata, M
    Sakai, N
    Ozono, K
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 139 (1-2) : 15 - 24
  • [34] Effects of 1,25-dihydroxyvitamin D3 on human epidermal melanocytes and melanoblasts
    Kawakami, Tamihiro
    Ohgushia, Akiko
    Hirobe, Tomohisa
    Soma, Yoshinao
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 76 (01) : 72 - 74
  • [35] SPECIFIC CYTOSOL RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3 IN HUMAN INTESTINE
    WECKSLER, WR
    MASON, RS
    NORMAN, AW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (04): : 715 - 717
  • [36] CHARACTERIZATION OF HUMAN 1,25-DIHYDROXYVITAMIN D3 RECEPTOR ANTIPEPTIDE ANTIBODIES
    TUOHIMAA, P
    BLAUER, M
    JAASKELAINEN, T
    ITKONEN, A
    LINDFORS, M
    MAHONEN, A
    PALVIMO, J
    VILJA, P
    MAENPAA, PH
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (07): : 649 - 657
  • [37] Regulation of calcium signaling in dendritic cells by 1,25-dihydroxyvitamin D3
    Shumilina, Ekaterina
    Xuan, Nguyen Thi
    Matzner, Nicole
    Bhandaru, Madhuri
    Zemtsova, Irina M.
    Lang, Florian
    FASEB JOURNAL, 2010, 24 (06): : 1989 - 1996
  • [38] Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3
    Chen, TC
    Holick, MF
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (01) : 72 - 78
  • [39] Induction of transplantation tolerance by 1,25-dihydroxyvitamin D3
    Adorini, L
    Penna, G
    Casorati, M
    Davalli, AM
    Gregori, S
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 58 - 59
  • [40] Regulation of gene expression by 1,25-dihydroxyvitamin D3
    DeLuca, HF
    CANCER AND NUTRITION, 1998, : 55 - 69